Trial Profile
A study comparing the effect of Everolimus versus calcineurin inhibitors in reducing new-onset post-transplant malignancies in patients who received liver transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Calcineurin inhibitors
- Indications Cancer
- Focus Therapeutic Use
- 17 Aug 2015 New trial record